Erector Spinae Plane Block (ESPB) Versus Quadratus Lumborum Block (QLB) for Postoperative Analgesia After Caesarean Section
Bilateral Erector Spinae Plane Block (ESPB) Versus Posterior Quadratus Lumborum Block (p-QLB) for Postoperative Analgesia After Caesarean Section: an Observational Closed Mixed Cohort Study
1 other identifier
observational
52
1 country
1
Brief Summary
Management of pain after caesarean section represents an important anesthesiologic issue, since it is often suboptimal, leading to delayed functional recovery and chronic pain. Currently, the postoperative analgesic strategy mostly relies on intrathecal morphine (ITM) and multimodal analgesic regimen. Recently, the need for alterative opioid sparing techniques is emerging. Paraspinal fascial plane blocks, as quadratus lumborum block (QLB) and erector spinae plane block (ESPB) performed at T9 level, have therefore been proposed as alternatives to ITM, because of their demonstrated effect on visceral and somatic pain. The aim of the study is to assess the efficacy, the feasibility and safety of bilateral ESPB compared to bilateral QLB for the management of postoperative pain after ceasarean section conducted under spinal anesthesia without ITM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2021
CompletedStudy Start
First participant enrolled
December 15, 2021
CompletedFirst Posted
Study publicly available on registry
April 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedOctober 17, 2023
October 1, 2023
10 months
December 15, 2021
October 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid consumption at 24 h
Total morphine consumption at 24 hours from block performance
24 hours from block performance
Secondary Outcomes (8)
Intensity of pain at time of block performance
Time of block performance, at the end of surgery
Intensity of pain at 2 hours
2 hours from block performance
Intensity of pain at 6 hours
6 hours from block performance
Intensity of pain at 12 hours
12 hours from block performance
Intensity of pain at 24 hours
24 hours from block performance
- +3 more secondary outcomes
Study Arms (2)
ESPB
A prospective cohort of 25 patients ASA 2 (according to American Society of Anesthesiologists physical status classification) with normal singleton pregnancy, scheduled for elective caesarean section under spinal anesthesia without intrathecal morphine, who underwent bilateral echo-guided ESPB at T9 level at the end of surgery.
p-QLB
A historical cohort of 25 patients ASA 2 (according to American Society of Anesthesiologists physical status classification) with normal singleton pregnancy, scheduled for elective caesarean section under spinal anesthesia without intrathecal morphine, who underwent bilateral echo-guided p-QLB at the end of surgery.
Interventions
Echo-guided bilateral ESPB performed at T9 level at the end of surgery with a mixture of ropivacaine 0.375% and epinephrine 5 mcg/mL 20 mL each side.
Eligibility Criteria
The study is an observational comparative study, including a prospective cohort (the ESPB group) and a historical control group (the p-QLB group) from our institution.
You may qualify if:
- \- Patients ASA 2 with normal singleton pregnancy, scheduled for elective caesarean section without intrathecal morphine, who underwent bilateral ESPB at the end of surgery an who gave informed consent to data collection.
You may not qualify if:
- Contraindications to spinal anesthesia;
- Contraindications to or a history of opioid dependence;
- Allergy to local anesthetics, acetaminophen, NSAIDs
- Inability to understand pain assessment scales or to use Patient Controlled Analgesia (PCA) pump;
- Patient refusal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Gemelli
Roma, RM, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician Anesthesiologist
Study Record Dates
First Submitted
December 15, 2021
First Posted
April 27, 2022
Study Start
December 15, 2021
Primary Completion
October 20, 2022
Study Completion
October 30, 2022
Last Updated
October 17, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share